Literature DB >> 3345492

Prognostic value of histologic factors in adult cerebral astrocytoma.

D Schiffer1, A Chiò, M T Giordana, M Leone, R Soffietti.   

Abstract

Surgical specimens from 165 adults with cerebral astrocytoma were reviewed to establish the prognostic value of histologic factors when studied both individually and in combination. Glioblastomas were excluded. Nine morphologic parameters and 25 clinicotherapeutic factors were correlated with survival. Cell density, endothelial hyperplasia, number of mitoses X 10 high-power field (HPF), and vessel frequency appeared to be highly significant prognostic factors (P less than 0.001). Nuclear polymorphism, microcysts, and vessel size were significant moderately (P less than 0.01). Microcysts, vessel size, endothelial hyperplasia, and number of mitoses X 10 HPF remained significant statistically after a multivariate analysis that also included clinicotherapeutic factors. Survival was similar for astrocytomas with "extensive malignancy" and astrocytomas with only "slight and localized malignancy." Multivariate analysis showed that the presence or absence of malignancy was more important prognostically than the clinical variables (i.e., postoperative Karnofsky status or extent of surgical removal).

Entities:  

Mesh:

Year:  1988        PMID: 3345492     DOI: 10.1002/1097-0142(19880401)61:7<1386::aid-cncr2820610719>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Prognostic value of histological features in diffuse astrocytomas WHO grade II.

Authors:  Tove Lind-Landström; Andreas Hanssøn Habberstad; Stein Sundstrøm; Sverre Helge Torp
Journal:  Int J Clin Exp Pathol       Date:  2012-02-12

Review 2.  Vascular microenvironment in gliomas.

Authors:  P Vajkoczy; M D Menger
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

3.  Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors.

Authors:  A M Ralte; M C Sharma; A K Karak; V S Mehta; C Sarkar
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

4.  The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient- and drug-specific variables.

Authors:  G Nikkhah; J C Tonn; O Hoffmann; H P Kraemer; J L Darling; W Schachenmayr; R Schönmayr
Journal:  J Neurooncol       Date:  1992-05       Impact factor: 4.130

5.  Clinicopathologic correlations in epithelial choroid plexus neoplasms: a study of 52 cases.

Authors:  W Paulus; W Jänisch
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Proliferating cell nuclear antigen expression in brain tumors, and its prognostic role in ependymomas: an immunohistochemical study.

Authors:  D Schiffer; A Chiò; M T Giordana; T Pezzulo; M C Vigliani
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  Stereological estimates of nuclear volume and other quantitative variables in supratentorial brain tumors. Practical technique and use in prognostic evaluation.

Authors:  F B Sørensen; H Braendgaard; A O Chistiansen; M Bojsen-Møller; E Reske-Nielsen
Journal:  J Neurooncol       Date:  1991-06       Impact factor: 4.130

8.  Histologic factors in the grading and prognosis of astrocytoma grade I-IV.

Authors:  E H Rutten; W H Doesburg; J L Slooff
Journal:  J Neurooncol       Date:  1992-07       Impact factor: 4.130

9.  p53 protein in low-grade astrocytomas: a study with long-term follow-up.

Authors:  P Iuzzolino; C Ghimenton; A Nicolato; F Giorgiutti; P Fina; C Doglioni; M Barbareschi
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.